We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Martin Marietta Materials
MLM
$32.8B
| $17.2M | 0.06% |
37,206
| – | – |
|
102
IBM
IBM
$194B
| $17M | 0.06% |
126,840
-31,441
| -20% | -$4.06M |
|
103
Evolus
EOLS
$394M
| $16.6M | 0.06% |
2,287,538
-1,728,600
| -43% | -$14.9M |
|
104
Commercial Metals
CMC
$7.53B
| $16.6M | 0.06% |
314,390
-79,194
| -20% | -$3.7M |
|
105
Howard Hughes
HHH
$3.92B
| $16M | 0.06% |
212,029
+6,488
| +3% | +$470K |
|
106
ConocoPhillips
COP
$146B
| $15.9M | 0.06% |
153,364
-2,054
| -1% | -$211K |
|
107
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $15.5M | 0.06% |
35,031
-1,682
| -5% | -$706K |
|
108
Union Pacific
UNP
$181B
| $15.3M | 0.06% |
74,693
-117,757
| -61% | -$23.4M |
|
109
Mirion Technologies
MIR
$4.13B
| $15.3M | 0.06% |
1,807,574
-10,440
| -0.6% | -$84.7K |
|
110
Automatic Data Processing
ADP
$97.1B
| $15.2M | 0.06% |
69,046
-7,103
| -9% | -$1.53M |
|
111
RPM International
RPM
$13.4B
| $14.2M | 0.05% |
158,484
-2,120
| -1% | -$174K |
|
112
IDEAYA Biosciences
IDYA
$3.49B
| $13.9M | 0.05% |
593,065
+427,865
| +259% | +$8.8M |
|
113
Middlesex Water
MSEX
$1.05B
| $13.8M | 0.05% |
171,621
-23,634
| -12% | -$1.85M |
|
114
Citigroup
C
$221B
| $13.4M | 0.05% |
291,753
+1,093
| +0.4% | +$51.2K |
|
115
Gates Industrial Corporation Ltd.
GTES
$6.84B
| $13.4M | 0.05% |
996,230
+279,560
| +39% | +$3.63M |
|
116
Agilent Technologies
A
$39.5B
| $12.5M | 0.05% |
103,558
+5,346
| +5% | +$681K |
|
117
Home Depot
HD
$324B
| $12.4M | 0.05% |
40,059
+2,619
| +7% | +$774K |
|
118
Range Resources
RRC
$9.08B
| $12.2M | 0.04% |
414,255
+1,365
| +0.3% | +$37.2K |
|
119
Douglas Emmett
DEI
$2.03B
| $11.8M | 0.04% |
939,985
+484,586
| +106% | +$5.86M |
|
120
Minerals Technologies
MTX
$2.27B
| $11.8M | 0.04% |
204,365
-5,301
| -3% | -$309K |
|
121
Yum! Brands
YUM
$40.6B
| $11.7M | 0.04% |
87,234
-3,764
| -4% | -$510K |
|
122
TMC The Metals Company
TMC
$1.65B
| $11.5M | 0.04% |
7,066,000
+1,156,000
| +20% | +$1.05M |
|
123
CarMax
KMX
$8.29B
| $11.3M | 0.04% |
134,874
+271
| +0.2% | +$19.8K |
|
124
Aon
AON
$76B
| $11.2M | 0.04% |
32,562
-780
| -2% | -$253K |
|
125
Navigator Holdings
NVGS
$1.34B
| $11.1M | 0.04% |
854,352
+9,433
| +1% | +$126K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.